The effect of socioeconomic status, race, and insurance type on newly diagnosed metastatic prostate cancer in the United States (2004–2013)

Understanding the characteristics of men who initially present with metastatic prostate cancer (mPCa) can better enable directed improvement initiatives. The objective of this study was to assess the relationship between socioeconomic status (SES) and newly diagnosed mPCa. All men diagnosed with PCa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Urologic oncology 2018-03, Vol.36 (3), p.91.e1-91.e6
Hauptverfasser: Weiner, Adam B., Matulewicz, Richard S., Tosoian, Jeffrey J., Feinglass, Joseph M., Schaeffer, Edward M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 91.e6
container_issue 3
container_start_page 91.e1
container_title Urologic oncology
container_volume 36
creator Weiner, Adam B.
Matulewicz, Richard S.
Tosoian, Jeffrey J.
Feinglass, Joseph M.
Schaeffer, Edward M.
description Understanding the characteristics of men who initially present with metastatic prostate cancer (mPCa) can better enable directed improvement initiatives. The objective of this study was to assess the relationship between socioeconomic status (SES) and newly diagnosed mPCa. All men diagnosed with PCa in the National Cancer Data Base from 2004 to 2013 were identified. Characteristics of men presenting with and without metastatic disease were compared. A 4-level composite metric of SES was created using Census-based income and education data. Multivariable logistic regression was used to evaluate the association between SES, race/ethnicity, and insurance and the risk of presenting with mPCa at the time of diagnosis. Of 1,034,754 patients diagnosed with PCa, 4% had mPCa at initial presentation. Lower SES (first vs. fourth quartile; odds ratio [OR] = 1.39, 95% CI: 1.35–1.44), black and Hispanic race/ethnicity (vs. white; OR = 1.47, 95% CI: 1.43–1.51 and OR = 1.22, 95% CI: 1.17–1.28, respectively), and having Medicaid or no insurance (vs. Medicare or private; OR = 3.91, 95% CI: 3.78–4.05) were each independently associated with higher odds of presenting with mPCa after adjusting for all other covariates. Lower SES, race/ethnicity, and having Medicaid or no insurance were each independently associated with higher odds of presenting with metastases at the time of PCa diagnosis. Our findings may partially explain current PCa outcomes disparities and inform future efforts to reduce disparities. •Low socioeconomic status was associated with mPCa diagnoses.•Nonwhite race and lack of insurance were also associated with mPCa.•Findings may explain and previously demonstrated disparities in PCa outcomes.
doi_str_mv 10.1016/j.urolonc.2017.10.023
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6048442</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1078143917305604</els_id><sourcerecordid>1966441648</sourcerecordid><originalsourceid>FETCH-LOGICAL-c467t-266c8fed8c969b38c24ef1fb6011471193d5853753a2d1e923f6e3447e9830c3</originalsourceid><addsrcrecordid>eNqFUc1u1DAQjhCIlsIjgHwsUrN4bMdxLlSo4k-qxIHlbHmdSetVYi-2U7Q3XoATb8iT4GiXCk6cPJr5fsbzVdVzoCugIF9tV3MMY_B2xSi0pbeijD-oTkG1vGaikw9LTVtVg-DdSfUkpS2lIBTA4-qEddBwycRp9WN9iwSHAW0mYSApWBfQBh8mZ0nKJs_pgkRj8YIY3xPn0xyNt0jyfockeOLx27gnvTM3PiTsyYTZLLxC38WwVEjswoiFTHJx--JdLsDPyyiRc0ap-PX9Z_kFf_m0ejSYMeGz43tWrd-9XV99qK8_vf949ea6tkK2uWZSWjVgr2wnuw1XlgkcYNhICiBagI73jWp423DDesCO8UEiF6LFTnFq-Vn1-iC7mzcT9hZ9jmbUu-gmE_c6GKf_nXh3q2_CnZZUKCFYETg_CsTwdcaU9eSSxXE0HsOcNHRSCgFSqAJtDlBbrpEiDvc2QPWSpN7qY5J6SXJplyQL78XfO96z_kRXAJcHAJZD3TmMOlmH5dC9iyVN3Qf3H4vfypa0Uw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1966441648</pqid></control><display><type>article</type><title>The effect of socioeconomic status, race, and insurance type on newly diagnosed metastatic prostate cancer in the United States (2004–2013)</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Weiner, Adam B. ; Matulewicz, Richard S. ; Tosoian, Jeffrey J. ; Feinglass, Joseph M. ; Schaeffer, Edward M.</creator><creatorcontrib>Weiner, Adam B. ; Matulewicz, Richard S. ; Tosoian, Jeffrey J. ; Feinglass, Joseph M. ; Schaeffer, Edward M.</creatorcontrib><description>Understanding the characteristics of men who initially present with metastatic prostate cancer (mPCa) can better enable directed improvement initiatives. The objective of this study was to assess the relationship between socioeconomic status (SES) and newly diagnosed mPCa. All men diagnosed with PCa in the National Cancer Data Base from 2004 to 2013 were identified. Characteristics of men presenting with and without metastatic disease were compared. A 4-level composite metric of SES was created using Census-based income and education data. Multivariable logistic regression was used to evaluate the association between SES, race/ethnicity, and insurance and the risk of presenting with mPCa at the time of diagnosis. Of 1,034,754 patients diagnosed with PCa, 4% had mPCa at initial presentation. Lower SES (first vs. fourth quartile; odds ratio [OR] = 1.39, 95% CI: 1.35–1.44), black and Hispanic race/ethnicity (vs. white; OR = 1.47, 95% CI: 1.43–1.51 and OR = 1.22, 95% CI: 1.17–1.28, respectively), and having Medicaid or no insurance (vs. Medicare or private; OR = 3.91, 95% CI: 3.78–4.05) were each independently associated with higher odds of presenting with mPCa after adjusting for all other covariates. Lower SES, race/ethnicity, and having Medicaid or no insurance were each independently associated with higher odds of presenting with metastases at the time of PCa diagnosis. Our findings may partially explain current PCa outcomes disparities and inform future efforts to reduce disparities. •Low socioeconomic status was associated with mPCa diagnoses.•Nonwhite race and lack of insurance were also associated with mPCa.•Findings may explain and previously demonstrated disparities in PCa outcomes.</description><identifier>ISSN: 1078-1439</identifier><identifier>EISSN: 1873-2496</identifier><identifier>DOI: 10.1016/j.urolonc.2017.10.023</identifier><identifier>PMID: 29153624</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adenocarcinoma - epidemiology ; Aged ; Continental Population Groups - statistics &amp; numerical data ; Epidemiology ; Humans ; Insurance, Health - statistics &amp; numerical data ; Male ; Medicaid - statistics &amp; numerical data ; Middle Aged ; Neoplasm metastasis ; Prostatic neoplasms ; Prostatic Neoplasms - epidemiology ; Registries - statistics &amp; numerical data ; Social Class ; United States ; United States - epidemiology</subject><ispartof>Urologic oncology, 2018-03, Vol.36 (3), p.91.e1-91.e6</ispartof><rights>2018 Elsevier Inc.</rights><rights>Copyright © 2018 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c467t-266c8fed8c969b38c24ef1fb6011471193d5853753a2d1e923f6e3447e9830c3</citedby><cites>FETCH-LOGICAL-c467t-266c8fed8c969b38c24ef1fb6011471193d5853753a2d1e923f6e3447e9830c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1078143917305604$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29153624$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Weiner, Adam B.</creatorcontrib><creatorcontrib>Matulewicz, Richard S.</creatorcontrib><creatorcontrib>Tosoian, Jeffrey J.</creatorcontrib><creatorcontrib>Feinglass, Joseph M.</creatorcontrib><creatorcontrib>Schaeffer, Edward M.</creatorcontrib><title>The effect of socioeconomic status, race, and insurance type on newly diagnosed metastatic prostate cancer in the United States (2004–2013)</title><title>Urologic oncology</title><addtitle>Urol Oncol</addtitle><description>Understanding the characteristics of men who initially present with metastatic prostate cancer (mPCa) can better enable directed improvement initiatives. The objective of this study was to assess the relationship between socioeconomic status (SES) and newly diagnosed mPCa. All men diagnosed with PCa in the National Cancer Data Base from 2004 to 2013 were identified. Characteristics of men presenting with and without metastatic disease were compared. A 4-level composite metric of SES was created using Census-based income and education data. Multivariable logistic regression was used to evaluate the association between SES, race/ethnicity, and insurance and the risk of presenting with mPCa at the time of diagnosis. Of 1,034,754 patients diagnosed with PCa, 4% had mPCa at initial presentation. Lower SES (first vs. fourth quartile; odds ratio [OR] = 1.39, 95% CI: 1.35–1.44), black and Hispanic race/ethnicity (vs. white; OR = 1.47, 95% CI: 1.43–1.51 and OR = 1.22, 95% CI: 1.17–1.28, respectively), and having Medicaid or no insurance (vs. Medicare or private; OR = 3.91, 95% CI: 3.78–4.05) were each independently associated with higher odds of presenting with mPCa after adjusting for all other covariates. Lower SES, race/ethnicity, and having Medicaid or no insurance were each independently associated with higher odds of presenting with metastases at the time of PCa diagnosis. Our findings may partially explain current PCa outcomes disparities and inform future efforts to reduce disparities. •Low socioeconomic status was associated with mPCa diagnoses.•Nonwhite race and lack of insurance were also associated with mPCa.•Findings may explain and previously demonstrated disparities in PCa outcomes.</description><subject>Adenocarcinoma - epidemiology</subject><subject>Aged</subject><subject>Continental Population Groups - statistics &amp; numerical data</subject><subject>Epidemiology</subject><subject>Humans</subject><subject>Insurance, Health - statistics &amp; numerical data</subject><subject>Male</subject><subject>Medicaid - statistics &amp; numerical data</subject><subject>Middle Aged</subject><subject>Neoplasm metastasis</subject><subject>Prostatic neoplasms</subject><subject>Prostatic Neoplasms - epidemiology</subject><subject>Registries - statistics &amp; numerical data</subject><subject>Social Class</subject><subject>United States</subject><subject>United States - epidemiology</subject><issn>1078-1439</issn><issn>1873-2496</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUc1u1DAQjhCIlsIjgHwsUrN4bMdxLlSo4k-qxIHlbHmdSetVYi-2U7Q3XoATb8iT4GiXCk6cPJr5fsbzVdVzoCugIF9tV3MMY_B2xSi0pbeijD-oTkG1vGaikw9LTVtVg-DdSfUkpS2lIBTA4-qEddBwycRp9WN9iwSHAW0mYSApWBfQBh8mZ0nKJs_pgkRj8YIY3xPn0xyNt0jyfockeOLx27gnvTM3PiTsyYTZLLxC38WwVEjswoiFTHJx--JdLsDPyyiRc0ap-PX9Z_kFf_m0ejSYMeGz43tWrd-9XV99qK8_vf949ea6tkK2uWZSWjVgr2wnuw1XlgkcYNhICiBagI73jWp423DDesCO8UEiF6LFTnFq-Vn1-iC7mzcT9hZ9jmbUu-gmE_c6GKf_nXh3q2_CnZZUKCFYETg_CsTwdcaU9eSSxXE0HsOcNHRSCgFSqAJtDlBbrpEiDvc2QPWSpN7qY5J6SXJplyQL78XfO96z_kRXAJcHAJZD3TmMOlmH5dC9iyVN3Qf3H4vfypa0Uw</recordid><startdate>20180301</startdate><enddate>20180301</enddate><creator>Weiner, Adam B.</creator><creator>Matulewicz, Richard S.</creator><creator>Tosoian, Jeffrey J.</creator><creator>Feinglass, Joseph M.</creator><creator>Schaeffer, Edward M.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20180301</creationdate><title>The effect of socioeconomic status, race, and insurance type on newly diagnosed metastatic prostate cancer in the United States (2004–2013)</title><author>Weiner, Adam B. ; Matulewicz, Richard S. ; Tosoian, Jeffrey J. ; Feinglass, Joseph M. ; Schaeffer, Edward M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c467t-266c8fed8c969b38c24ef1fb6011471193d5853753a2d1e923f6e3447e9830c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adenocarcinoma - epidemiology</topic><topic>Aged</topic><topic>Continental Population Groups - statistics &amp; numerical data</topic><topic>Epidemiology</topic><topic>Humans</topic><topic>Insurance, Health - statistics &amp; numerical data</topic><topic>Male</topic><topic>Medicaid - statistics &amp; numerical data</topic><topic>Middle Aged</topic><topic>Neoplasm metastasis</topic><topic>Prostatic neoplasms</topic><topic>Prostatic Neoplasms - epidemiology</topic><topic>Registries - statistics &amp; numerical data</topic><topic>Social Class</topic><topic>United States</topic><topic>United States - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Weiner, Adam B.</creatorcontrib><creatorcontrib>Matulewicz, Richard S.</creatorcontrib><creatorcontrib>Tosoian, Jeffrey J.</creatorcontrib><creatorcontrib>Feinglass, Joseph M.</creatorcontrib><creatorcontrib>Schaeffer, Edward M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Urologic oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Weiner, Adam B.</au><au>Matulewicz, Richard S.</au><au>Tosoian, Jeffrey J.</au><au>Feinglass, Joseph M.</au><au>Schaeffer, Edward M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The effect of socioeconomic status, race, and insurance type on newly diagnosed metastatic prostate cancer in the United States (2004–2013)</atitle><jtitle>Urologic oncology</jtitle><addtitle>Urol Oncol</addtitle><date>2018-03-01</date><risdate>2018</risdate><volume>36</volume><issue>3</issue><spage>91.e1</spage><epage>91.e6</epage><pages>91.e1-91.e6</pages><issn>1078-1439</issn><eissn>1873-2496</eissn><abstract>Understanding the characteristics of men who initially present with metastatic prostate cancer (mPCa) can better enable directed improvement initiatives. The objective of this study was to assess the relationship between socioeconomic status (SES) and newly diagnosed mPCa. All men diagnosed with PCa in the National Cancer Data Base from 2004 to 2013 were identified. Characteristics of men presenting with and without metastatic disease were compared. A 4-level composite metric of SES was created using Census-based income and education data. Multivariable logistic regression was used to evaluate the association between SES, race/ethnicity, and insurance and the risk of presenting with mPCa at the time of diagnosis. Of 1,034,754 patients diagnosed with PCa, 4% had mPCa at initial presentation. Lower SES (first vs. fourth quartile; odds ratio [OR] = 1.39, 95% CI: 1.35–1.44), black and Hispanic race/ethnicity (vs. white; OR = 1.47, 95% CI: 1.43–1.51 and OR = 1.22, 95% CI: 1.17–1.28, respectively), and having Medicaid or no insurance (vs. Medicare or private; OR = 3.91, 95% CI: 3.78–4.05) were each independently associated with higher odds of presenting with mPCa after adjusting for all other covariates. Lower SES, race/ethnicity, and having Medicaid or no insurance were each independently associated with higher odds of presenting with metastases at the time of PCa diagnosis. Our findings may partially explain current PCa outcomes disparities and inform future efforts to reduce disparities. •Low socioeconomic status was associated with mPCa diagnoses.•Nonwhite race and lack of insurance were also associated with mPCa.•Findings may explain and previously demonstrated disparities in PCa outcomes.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>29153624</pmid><doi>10.1016/j.urolonc.2017.10.023</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1078-1439
ispartof Urologic oncology, 2018-03, Vol.36 (3), p.91.e1-91.e6
issn 1078-1439
1873-2496
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6048442
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adenocarcinoma - epidemiology
Aged
Continental Population Groups - statistics & numerical data
Epidemiology
Humans
Insurance, Health - statistics & numerical data
Male
Medicaid - statistics & numerical data
Middle Aged
Neoplasm metastasis
Prostatic neoplasms
Prostatic Neoplasms - epidemiology
Registries - statistics & numerical data
Social Class
United States
United States - epidemiology
title The effect of socioeconomic status, race, and insurance type on newly diagnosed metastatic prostate cancer in the United States (2004–2013)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T09%3A39%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20effect%20of%20socioeconomic%20status,%20race,%20and%20insurance%20type%20on%20newly%20diagnosed%20metastatic%20prostate%20cancer%20in%20the%20United%20States%20(2004%E2%80%932013)&rft.jtitle=Urologic%20oncology&rft.au=Weiner,%20Adam%20B.&rft.date=2018-03-01&rft.volume=36&rft.issue=3&rft.spage=91.e1&rft.epage=91.e6&rft.pages=91.e1-91.e6&rft.issn=1078-1439&rft.eissn=1873-2496&rft_id=info:doi/10.1016/j.urolonc.2017.10.023&rft_dat=%3Cproquest_pubme%3E1966441648%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1966441648&rft_id=info:pmid/29153624&rft_els_id=S1078143917305604&rfr_iscdi=true